MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Device_Diagnostics
deepull*
Organization & Developments: deepull
Parents
deepull*
Children
*deepull Is a Medical Diagnostics Company Developing Culture-free Diagnostic Solutions for Sepsis and Acute Infections.
*Developing new diagnostic to detect pathogens and antibiotic resistance without a prior cultivation
*Reduces unnecessary use of antimicrobials
*UllCORE bloodstream infection (BSI) test is a real-time multiplex PCR system that analyses and extracts microbial deoxyribose nucleic acid (DNA) directly from 8ml of whole blood bypassing traditional blood culture methods
*Uses artificial intelligence to identify the infective agents and provide phenotypic antimicrobial susceptibility results.
2024: deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
2024: FDA grants breakthrough device designation to deepull’s BSI test
Jumps
Finance & Acquisition: deepull
Key People: deepull